Share

    


Home / Search Results

Search Results

Search Publications

Search Again?

Filter By Content Type

Filter By Topic

The ACCC Oncology Reimbursement Meetings (ORMs) help all members of the multidisciplinary cancer care team navigate the annual changes in oncology reimbursement and regulations— while improving their knowledge on effective strategies for success in an everchanging oncology landscape. In this episode, CANCER BUZZ speaks with Jordan Karwedsky, financial counselor, Green Bay Oncology, about her …
Julia Trosman, PhD Trosman@centerforbusinessmodels.com An Actionable Framework to Support Equitable and Comprehensive Care 4R Oncology® Josephine Louella Feliciano, MD Medical Director, Thoracic Oncology Program; Co-director of the Outpatient Oncology Clinic, Johns Hopkins Bayview Medical Center Presenters Julia Trosman, PhD, MBA Director, Center for Business Models …
Support HB 1624 to Protect Parenthood After Cancer Give young adult Hawaiian cancer patients hope by providing access to treatments that will protect their ability to have biological children in the future. The National Cancer Institute estimates 334 Adolescent and Young Adult Hawaiians between the ages of 15- 39 will be diagnosed with cancer this year. The Need Some …
March 21, 2024
You’re invited to participate in the Targeted Oncology™ and Oncology Nursing News® Community Case Forum™ on Thursday, March 21 at The Bankers Alley Hotel in Nashville, Tennessee. Healthcare Research & Analytics offers compensation of $750 to medical oncologists/hematologists and $500 to advanced practice providers for their consultative insights. After arriving, you’ll spend some time networking …
Explore findings from a multi-stakeholder collaboration aimed at exploring clinical meaningfulness in comprehensive care delivery for patients with metastatic breast cancer.
KaSCO 2024 Spring Conference Saturday April 13, 2024 Sheraton Overland Park Hotel at the Convention Center Overland Park, KS Attendee Roster First Name Last Name Title Account Name Scott Bennett Corporate Account Director BeiGene Sarah Oboyle MKT CMI Micky Jones Sr. Territory Manager, Onc II Breast Daiichi Sankyo, Inc. Becca Diederich Executive Oncology Account Manager …
TACOS 2024 Spring Conference Saturday April 13, 2024 DoubleTree Resort by Hilton Hotel Paradise Valley Scottsdale, AZ Attendee Roster First Name Last Name Title Account Name Christina DeRose Corporate Relations ACCC Ruth Walker - Simelton Practice Manager Alliance Cancer Care Arizona Brian Hummell AZ Director of Government Relations, ACS CAN American Cancer Society Cancer …
LOS 2024 Cancer Congress Friday April 19 - Saturday April 20, 2024 Marriott New Orleans Warehouse Arts District New Orleans, LA Attendee Roster First Name Last Name Title Account Name Sam Farrington DHS Adaptive Biotechnologies Ashley Gilliland Nurse Practitioner Adaptive Biotechnologies Amanda Impellizzeri Executive Director Association of Cancer Care Centers (ACCC) Gina …
1 An Inside Look at Precision Medicine Stewardship at TriHealth Cancer and Blood Institute Diffuse Large B-cell Lymphoma Communication Roadmap (DLBCL) ASSOCIATION OF CANCER CARE CENTERS Diagnosis/Prognosis • The most common, aggressive type of lymphoma • DLBCL is considered curable. 60-70% of patients will be cured with 1L therapy4 • Use data from clinical trials to provide estimates …
ASSOCIATION OF CANCER CARE CENTERS 1 ASSOCIATION OF CANCER CARE CENTERS DIFFUSE LARGE B-CELL LYMPHOMA LANDSCAPE ANALYSIS 2 Landscape Analysis for Diffuse Large B-Cell Lymphoma TABLE OF CONTENTS Brief Overview 3 Unmet Needs 3 Recent Advancements 6 Clinical Challenges in Treating DLBCL Patients 7 Non-Clinical Challenges in Treating DLBCL Patients …
March 18, 2024
You’re invited to participate in the Targeted Oncology™ and Oncology Nursing News® Community Case Forum™ on Monday, March 18 at The Marquette Hotel in Minneapolis, Minnesota. Healthcare Research & Analytics offers compensation of $750 to medical oncologists/hematologists and $500 to advanced practice providers for their consultative insights. The evening begins with a reception at the Topgolf …
ASSESSING THE STATUS OF BRCA TESTING: REASSESSMENT 1 ASSOCIATION OF CANCER CARE CENTERS ASSESSING THE STATUS OF BRCA TESTING AND CHALLENGES FACED BY PATIENTS AND CANCER CARE TEAMS: BRCA TESTING REASSESSMENT Summary of Survey Findings 2 ASSOCIATION OF CANCER CARE CENTERS TABLE OF CONTENTS Introduction 3 Changes in BRCA1/2 Testing between 2018 …
ASSOCIATION OF CANCER CARE CENTERS 1 ASSOCIATION OF CANCER CARE CENTERS LUNG CANCER SCREENING IMPLEMENTATION CHANGE PACKAGE 2 Lung Cancer Screening Implementation Change Package WHAT IS THE LUNG CANCER SCREENING IMPLEMENTATION CHANGE PACKAGE? The Lung Cancer Screening Implementation Change Package (Change Package) is a toolkit of information that can inform …
March 16, 2024
Expressing Breast Cancer… Advances in Management from HER2-Low to Positive Disease This live, virtual PER symposium in partnership with NMSCO will bring together a nationally recognized expert in the management of breast cancer and a local thought leader to present key data that guide clinical decision-making in the context of real-world clinical scenarios Learn More
March 14, 2024
Illuminating the Crossroads of Precision Medicine and Targeted Treatment Options in AML This live, virtual PER program in partnership with MOS will provide an in-depth review of current practices and guideline-based recommendations for the management of patients with acute myeloid leukemia (AML). Learn More
Explore key takeaways from a meeting between ACCC, Inova Schar Cancer Institute, and delegates from the Swedish Ministry of Health and Social Affairs.
Maintenance therapy for patients with acute myeloid leukemia, particularly those who are ineligible for transplant, can be critical to treatment outcomes and quality of life for patients. In this episode, CANCER BUZZ speaks with Thomas LeBlanc, MD, hematologic oncologist, associate professor of Medicine, and associate professor in Population Health Sciences at Duke Cancer Institute, about the importance …
This content is being shared with permission from MJH Life Sciences. All content of Targeted Oncology is independently created and owned by MJH Life Sciences. TACOS ONCOLOGY DRUG NEWSLETTER M A R C H 2 0 2 4 FDA APPROVALS Axicabtagene Ciloleucel (Axi-Cel; Yescarta) The FDA has approved a manufacturing process change resulting in a shorter manufacturing time for axicabtagene ciloleucel …